Chlamydia trachomatis is a gram-negative, ovoid, non-motile, obligate intracellular bacterium. It is the second most common non-viral STI after trichomoniasis.
- Risk factors
- < 25 years old
- Presence of other STIs e.g. HIV, syphillis, hepatitis
- History of gonorrhoeal infection
- New or multiple sex partners
- Unprotected sex
- Commercial sex work
- Drug use
- Signs and symptoms
- Mucopurulent discharge
- Dysuria
- Lower abdominal pain
- Cervicitis – Hyperemic, edematous endocervical tissue
- Investigations
- Nucleic Acid Amplification Test (NAAT) for gonorrhea and chlamydia
- The sample is a first-void urine or cervical/vaginal discharge
- Rectal or phrayngeal swabs can also be used
- NAAT is highly sensitive and specific
- Culture and sensitivity for antimicrobial resistance
- Test for other STIs
- Nucleic Acid Amplification Test (NAAT) for gonorrhea and chlamydia
- Treatment
- Single-dose Azithromycin can be used alone if gonorrhoea and trichomoniasis is negative
- Doxycycline for anorectal chlamydia
- Refer sexual partners for treatment or Expedited partner treatment
- Abstinence until the patient and sexual partners are treated
- Complications of chlamydia
- Reactive arthritis
- Pelvic inflammatory disease in women
- Fitz-hugh curtis syndrome
- Acute epididymitis in men
- Congenital chlamydia
- Bilateral conjunctivitis with water to purulent discharge 5 – 14 days after birth